Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-07 Sale |
2025-03-07 5:25 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Keenan Greg Chief Medical Officer |
8,305 | $8.23 | $68,350 | 153,484 (Direct) |
View |
| 2025-03-03 Sale |
2025-03-04 9:02 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Greenleaf Peter Chief Executive Officer |
360,540 | $7.9634 | $2,871,124 | 2,232,918 (Direct) |
View |
| 2025-03-03 Sale |
2025-03-04 8:59 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Keenan Greg Chief Medical Officer |
12,239 | $8 | $97,912 | 257,359 (Direct) |
View |
| 2025-03-03 Sale |
2025-03-04 8:58 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Miller Joseph M Chief Financial Officer |
118,013 | $7.9619 | $939,612 | 701,754 (Direct) |
View |
| 2025-03-03 Sale |
2025-03-04 8:57 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Robertson Stephen P. EVP, General Counsel |
122,479 | $7.9624 | $975,223 | 637,714 (Direct) |
View |
| 2025-03-03 Sale |
2025-03-04 8:56 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Donley Matthew Maxwell Chief Operating Officer |
124,893 | $7.9622 | $994,425 | 806,881 (Direct) |
View |
| 2025-02-28 Purchase |
2025-03-04 5:03 pm |
Aurinia Pharmaceuticals Inc. | AUPH | TANG KEVIN Director |
1,600,000 | $7.9457 | $12,713,126 | 10,029,500 (Indirect) |
View |
| 2024-12-05 Purchase |
2024-12-09 4:52 pm |
Aurinia Pharmaceuticals Inc. | AUPH | TANG KEVIN Director |
1,200,000 | $9.0183 | $10,822,000 | 8,429,500 (Indirect) |
View |
| 2024-11-11 Sale |
2024-11-12 7:29 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Bailey Jeffrey Allen Director |
4,557 | $8.43 | $38,416 | 13,356 (Direct) |
View |
| 2024-11-11 Sale |
2024-11-12 7:20 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Smith Karen L. Director |
5,241 | $8.43 | $44,182 | 12,672 (Direct) |
View |
| 2024-08-06 Sale |
2024-08-08 4:06 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Habig Scott Michael Chief Commercial Officer |
18,249 | $5.31 | $96,902 | 456,338 (Direct) |
View |
| 2024-05-21 Sale |
2024-05-22 4:16 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Balakrishnan Brinda Director |
520 | $5.74 | $2,985 | 17,523 (Direct) |
View |
| 2024-05-21 Sale |
2024-05-22 4:14 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Billen Daniel Director |
5,252 | $5.74 | $30,146 | 28,141 (Direct) |
View |
| 2024-05-21 Sale |
2024-05-22 4:11 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Jayne David R.W. Director |
4,946 | $5.74 | $28,390 | 44,364 (Direct) |
View |
| 2024-05-21 Sale |
2024-05-22 4:09 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Leversage Jill Director |
5,610 | $5.74 | $32,201 | 12,918 (Direct) |
View |
| 2024-05-21 Sale |
2024-05-22 4:07 pm |
Aurinia Pharmaceuticals Inc. | AUPH | MacKay-Dunn R. Hector Director |
5,630 | $5.74 | $32,316 | 18,595 (Direct) |
View |
| 2024-03-06 Sale |
2024-03-07 4:46 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Greenleaf Peter Chief Executive Officer |
126,981 | $5.6 | $711,094 | 1,522,114 (Direct) |
View |
| 2024-03-06 Sale |
2024-03-07 4:44 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Miller Joseph M Chief Financial Officer |
34,811 | $5.6 | $194,942 | 495,928 (Direct) |
View |
| 2024-03-06 Sale |
2024-03-07 4:43 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Donley Matthew Maxwell EVP, Ops & Strategy |
40,665 | $5.51 | $224,064 | 584,072 (Direct) |
View |
| 2024-03-06 Sale |
2024-03-07 4:42 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Habig Scott Michael Chief Commercial Officer |
17,777 | $5.6 | $99,551 | 474,587 (Direct) |
View |
| 2024-03-06 Sale |
2024-03-07 4:41 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Robertson Stephen P. EVP, General Counsel |
57,745 | $5.6 | $323,372 | 443,824 (Direct) |
View |
| 2024-02-27 Sale |
2024-02-29 4:11 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Knappertz Volker EVP, Research and Development |
4,930 | $6.1 | $30,073 | 319,128 (Direct) |
View |
| 2024-02-20 Sale |
2024-02-22 4:35 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Knappertz Volker EVP, Research and Development |
25,146 | $5.48 | $137,800 | 324,058 (Direct) |
View |
| 2024-02-20 Sale |
2024-02-22 4:33 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Habig Scott Michael Chief Commercial Officer |
15,867 | $5.48 | $86,951 | 492,364 (Direct) |
View |
| 2023-03-02 Sale(A) |
2024-02-22 4:19 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Robertson Stephen P. EVP, General Counsel |
19,644 | $8.78 | $172,474 | 303,122 (Direct) |
View |
| 2023-03-02 Sale(A) |
2024-02-22 4:17 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Miller Joseph M Chief Financial Officer |
11,398 | $8.78 | $100,074 | 331,112 (Direct) |
View |
| 2023-03-02 Sale(A) |
2024-02-22 4:15 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Greenleaf Peter Chief Executive Officer |
33,047 | $8.78 | $290,153 | 982,671 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-28 Option Award |
2025-03-04 9:02 pm |
N/A 2035-02-28 |
Aurinia Pharmaceuticals Inc. | AUPH | Greenleaf Peter Chief Executive Officer |
1,068,406 | $0 | 2,232,918 (Direct) |
View |
| 2025-02-28 Option Award |
2025-03-04 8:59 pm |
N/A 2035-02-28 |
Aurinia Pharmaceuticals Inc. | AUPH | Keenan Greg Chief Medical Officer |
158,153 | $0 | 257,359 (Direct) |
View |
| 2025-02-28 Option Award |
2025-03-04 8:58 pm |
N/A 2035-02-28 |
Aurinia Pharmaceuticals Inc. | AUPH | Miller Joseph M Chief Financial Officer |
320,561 | $0 | 701,754 (Direct) |
View |
| 2025-02-28 Option Award |
2025-03-04 8:57 pm |
N/A 2035-02-28 |
Aurinia Pharmaceuticals Inc. | AUPH | Robertson Stephen P. EVP, General Counsel |
314,950 | $0 | 637,714 (Direct) |
View |
| 2025-02-28 Option Award |
2025-03-04 8:56 pm |
N/A 2035-02-28 |
Aurinia Pharmaceuticals Inc. | AUPH | Donley Matthew Maxwell Chief Operating Officer |
344,764 | $0 | 806,881 (Direct) |
View |
| 2024-11-21 Option Award |
2024-11-25 4:38 pm |
N/A 2034-11-21 |
Aurinia Pharmaceuticals Inc. | AUPH | Smith Karen L. Director |
30,776 | $0 | 43,448 (Direct) |
View |
| 2024-11-21 Option Award |
2024-11-25 4:36 pm |
N/A 2034-11-21 |
Aurinia Pharmaceuticals Inc. | AUPH | Leversage Jill Director |
30,776 | $0 | 43,694 (Direct) |
View |
| 2024-11-21 Option Award |
2024-11-25 4:33 pm |
N/A 2034-11-21 |
Aurinia Pharmaceuticals Inc. | AUPH | Johnson Craig A Director |
52,319 | $0 | 52,319 (Direct) |
View |
| 2024-11-21 Option Award |
2024-11-25 4:30 pm |
N/A 2034-11-21 |
Aurinia Pharmaceuticals Inc. | AUPH | Bailey Jeffrey Allen Director |
30,776 | $0 | 44,132 (Direct) |
View |
| 2024-11-21 Option Award |
2024-11-25 4:28 pm |
N/A 2034-11-21 |
Aurinia Pharmaceuticals Inc. | AUPH | Jayne David R.W. Director |
30,776 | $0 | 75,140 (Direct) |
View |
| 2024-11-08 Exercise |
2024-11-12 7:29 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Bailey Jeffrey Allen Director |
17,913 | $0 | 13,356 (Direct) |
View |
| 2024-11-08 Exercise |
2024-11-12 7:20 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Smith Karen L. Director |
17,913 | $0 | 12,672 (Direct) |
View |
Ownership |
2024-11-12 7:05 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Keenan Greg Chief Medical Officer |
0 | $0 | 193,435 (Direct) |
View |
Ownership |
2024-09-23 4:05 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | TANG KEVIN Director |
0 | $0 | 10,229,500 (Indirect) |
View |
| 2024-02-20 Option Award |
2024-02-22 4:33 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Habig Scott Michael Chief Commercial Officer |
195,512 | $0 | 492,364 (Direct) |
View |
| 2024-02-20 Option Award |
2024-02-22 4:31 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Donley Matthew Maxwell EVP, Ops & Strategy |
216,666 | $0 | 624,737 (Direct) |
View |
| 2024-02-20 Option Award |
2024-02-22 4:29 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Robertson Stephen P. EVP, General Counsel |
194,230 | $0 | 501,569 (Direct) |
View |
| 2024-02-20 Option Award |
2024-02-22 4:27 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Miller Joseph M Chief Financial Officer |
196,153 | $0 | 530,739 (Direct) |
View |
| 2024-02-20 Option Award |
2024-02-22 4:25 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Greenleaf Peter Chief Executive Officer |
661,538 | $0 | 1,649,095 (Direct) |
View |